In patients with gout initiating urate-lowering therapy, the risk of cardiovascular events was reduced in those prescribed colchicine prophylaxis compared with no prophylaxis. These findings provide an additional argument for using colchicine for gout flare prophylaxis.
Objectives Endogenous retroelements (EREs) stimulate type 1 interferon (IFN-I) production but have not been explored as potential interferonogenic triggers in Rheumatoid Arthritis (RA). We investiga…
ing research, it remains unknown whether somatosensory changes are a cause or effect of pain or if they are driven by other potentially confounding factors.…
The health-care system in Malawi provides substantial health gains with scarce resources. Strengthening interventions could potentially increase these gains, so should be a priority for…
Diabetes subtypes already differ in PROs at diabetes diagnosis. Our analyses had limited predictive power during follow-up. However, our findings suggest that clustering could predict…
Recognition of the heterogeneous causes of diabetes should help improve prevention, treatment, and the ability to predict progression and complications.1 In 2018, Ahlqvist and colleagues2…
In The Lancet Rheumatology, Edoardo Cipolletta and colleagues present an observational study comparing the risk of cardiovascular events in patients with gout initiating urate-lowering therapy…
b functional limitations. Briefly, the movement pattern is very similar to walking and running. This review includes studies from scientific databases and content of official…
